SB 1638: Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs
Latest action, March 13, 2026: Died in Banking and Insurance
Prohibiting drug manufacturers from engaging in certain acts relating to the acquisition of 340B drugs by and the delivery of such drugs to specified pharmacies; prohibiting health insurance issuers, pharmacy benefit managers, and other third-party payors, and agents thereof, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs; prohibiting individual health insurers, group, blanket, and franchise health insurers, and health maintenance organizations, respectively, and pharmacy benefit managers on behalf of such insurers and health maintenance organizations, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs, etc.
The bill’s record: its number and title, where it stands, its sponsors, every action in its legislature’s words, every version, the roll calls on it, and every change the site recorded, with LegiScan’s license.